PharmX Technologies Limited (ASX:PHX)
0.0760
0.00 (0.00%)
Last updated: Apr 24, 2025
PharmX Technologies Revenue
PharmX Technologies had revenue of 3.77M AUD in the half year ending December 31, 2024, with 22.42% growth. This brings the company's revenue in the last twelve months to 8.63M, up 37.45% year-over-year. In the fiscal year ending June 30, 2024, PharmX Technologies had annual revenue of 8.09M with 32.10% growth.
Revenue (ttm)
8.63M
Revenue Growth
+37.45%
P/S Ratio
5.27
Revenue / Employee
79.19K
Employees
109
Market Cap
45.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 8.09M | 1.97M | 32.10% |
Jun 30, 2023 | 6.13M | 742.00K | 13.78% |
Jun 30, 2022 | 5.39M | -6.49M | -54.65% |
Jun 30, 2021 | 11.88M | 1.23M | 11.58% |
Jun 30, 2020 | 10.64M | -587.00K | -5.23% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |